N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Etoposide
Related studies linked through entity extraction aliases.
Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC
- Status
- RECRUITING
- Phase
- PHASE2
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
- Status
- RECRUITING
- Phase
- PHASE2
MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
- Status
- RECRUITING
- Phase
- PHASE2
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE3
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
- Status
- RECRUITING
- Phase
- PHASE2
DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Atezolizumab in Large Cell Neuroendocrine Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
- Status
- SUSPENDED
- Phase
- PHASE2
Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE2